In 2002, the ‘Corngate’ controversy broke in the media. Journalist John Campbell blindsided then-PM Helen Clark with allegations that genetically modified (GM) corn had been accidentally released in New Zealand.  
 
Corngate has cast a shadow over New Zealand's approach to GM ever since. For over two decades, the political fallout has contributed to an ultra-cautious regulatory environment hampering scientific progress and innovation. 
 
New Zealand’s outdated approach to GM is a potent illustration of the culture of ‘no’ holding the country back. However, the recent introduction of the Gene Technology Bill marks a significant shift towards a more balanced approach. 
 
Current restrictions are so severe that New Zealand scientists often conduct their research overseas rather than navigate complex domestic approval processes. 
 
A prime example is AgResearch's ryegrass project, which could help reduce livestock greenhouse gas emissions. Field trials had to be conducted offshore, a lost opportunity for New Zealand agriculture. 
 
The Bill, inspired by Australia’s Gene Technology Act, would replace the current one-size-fits-all approach with a risk-based system. Medical researchers would be able to develop new treatments more efficiently. Agricultural scientists could work on climate-resilient crops and innovative pest control solutions. Oversight would focus on managing genuine risks rather than on bureaucratic compliance. 
 
Critics have raised concerns about potential impacts on agricultural exports and New Zealand's "clean, green" image. These concerns can be effectively managed. Australia's more enabling legislation demonstrates that a thriving organic sector can co-exist with significant GM research and development.  
 
Co-existence approaches include buffer zones, adjusting planting dates to avoid overlapping flowering periods, using sterile GM plants or seedless varieties, and other measures like crop rotation, dedicated machinery for GM and non-GM plants, and clear labelling. 
 
The Bill would see an independent regulator within the Environmental Protection Authority, supported by technical and Māori advisory committees. It should allow applications to be efficiently assessed and make conditions on approvals proportionate to the risks posed. 
 
Prime Minister Luxon has emphasised that embracing growth and innovation is essential for New Zealand's future prosperity. The Gene Technology Bill will be a key contributor. 
 
Productivity growth has stalled. New Zealand needs new tools to give it a kickstart. The time has come to move beyond the restrictive legacy of Corngate and create a regulatory environment that enables rather than impedes innovation.